PTEO — Proteo Income Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual income statement for Proteo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2015 December 31st | 2016 December 31st | R2017 December 31st | C2018 December 31st | 2019 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.826 | 0.243 | 0.199 | 0.206 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 1.3 | 0.34 | 0.27 | 0.209 | 0.245 |
| Operating Profit | -0.474 | -0.098 | -0.071 | -0.003 | -0.245 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.312 | -0.034 | -0.145 | 0.039 | -0.221 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.312 | -0.034 | -0.145 | 0.039 | -0.221 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.312 | -0.034 | -0.145 | 0.036 | -0.218 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.312 | -0.034 | -0.145 | 0.036 | -0.218 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -131 | -14.1 | -60.8 | 15.1 | -87.8 |